Complete Guide to Immune & Inflammation Research Peptides UK

Immune and inflammation research peptides modulate the immune system through diverse mechanisms, making them valuable tools for studying immunology, inflammatory biology and gut health research.

Anti-Inflammatory Peptides: KPV (Lys-Pro-Val) is the C-terminal tripeptide of alpha-MSH studied for potent anti-inflammatory properties via melanocortin receptor activation in immune cells, NF-κB signalling inhibition and potential applications in gut inflammation research. Research has examined its effects on intestinal epithelial barrier function and inflammatory bowel research models.

Neuropeptide Immunomodulation: VIP (Vasoactive Intestinal Peptide) is a 28 amino acid neuropeptide with potent immunomodulatory properties studied via VPAC1 and VPAC2 receptors. Research examines its inhibition of pro-inflammatory cytokine production, promotion of regulatory T cell activity and autonomic nervous system functions. LL-37 is the sole human cathelicidin, studied for antimicrobial activity, innate immunity stimulation and wound healing — with an extensive published literature across multiple research domains.

Thymic Peptides: Thymosin Alpha-1 is secreted by the thymus and studied for T-cell maturation, dendritic cell activation and cytokine modulation. Thymulin is a nonapeptide produced by thymic epithelial cells studied for T-cell differentiation and immune function in ageing models.

Gut Barrier Research: Larazotide is studied as a tight junction regulator examining intestinal permeability and coeliac disease research models. Bronchogen and Retinalamin are organ-specific bioregulators studied for pulmonary and retinal tissue research respectively.

All immune research peptides from UK Peptides are supplied at 99%+ HPLC purity for research use only.

⚠️ Research Disclaimer: This guide is for informational and scientific research context only. All UK Peptides compounds are sold strictly for laboratory research. Not for human consumption.